LSTA LISATA THERAPEUTICS INC Management Changes 8-K Filing 2024 - Appointment of James Nisco Lisata Therapeutics appoints James Nisco as Senior VP, Finance and Treasury and Chief Accounting Officer.Get access to all SEC 8-K filings of the LISATA THERAPEUTICS INC